24-norursodeoxycholic acid has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ | 1 |
| Alteneder, M; Baazim, H; Bergthaler, A; Boucheron, N; Claudel, T; Donner, C; Ellmeier, W; Fuchs, CD; Gülich, AF; Hainberger, D; Halilbasic, E; Hamminger, P; Khan, M; Lercher, A; Májek, P; Müller, AC; Ohradanova-Repic, A; Preglej, T; Remetic, J; Sakaguchi, S; Sandner, L; Scharnagl, H; Schatzlmaier, P; Stockinger, H; Stojakovic, T; Trauner, M; Viczenczova, C; Weichhart, T; Zhu, C | 1 |
| Fickert, P; Krones, E; Pollheimer, MJ; Rosenkranz, AR | 1 |
| Blomenkamp, KS; Fickert, P; Tang, Y; Teckman, JH; Trauner, M | 1 |
| Claudel, T; Engelmann, R; Fickert, P; Fuchs, CD; Guenther, ND; Langner, C; Loebermann, M; Mueller, M; Mueller-Hilke, B; Österreicher, CH; Reisinger, EC; Sahin, E; Schramm, C; Schwinge, D; Sombetzki, M; Trauner, M | 1 |
| Halilbasic, E; Kuntner, C; Langer, O; Mairinger, S; Müller, M; Römermann, K; Stieger, B; Trauner, M; Visentin, M; Wanek, T | 1 |
| Blomenkamp, K; Fickert, P; Marcus, N; Tang, Y; Teckman, J; Trauner, M | 1 |
| Eller, K; Fickert, P; Frauscher, B; Grahammer, F; Huber, TB; Kirsch, AH; Krones, E; Marschall, HU; Pollheimer, MJ; Racedo, S; Rosenkranz, AR; Ståhlman, M; Trauner, M; Wagner, K; Wahlström, A | 1 |
| Fabris, L; Fiorotto, R; Hoque, R; Scirpo, R; Spirli, C; Strazzabosco, M; Trauner, M | 1 |
| Fauler, G; Fickert, P; Frank, S; Guelly, C; Gumhold, J; Höfler, G; Kratky, D; Lass, A; Magnes, C; Moustafa, T; Reicher, H; Sattler, W; Silbert, D; Sinner, F; Thueringer, A; Trauner, M; Zechner, R | 1 |
| Cover, C; Denk, H; Fickert, P; Fuchsbichler, A; Hofmann, AF; Jaeschke, H; Liu, J; Marschall, HU; Trauner, M; Tsybrovskyy, O; Waalkes, MP; Wagner, M; Zatloukal, K; Zollner, G | 1 |
2 review(s) available for 24-norursodeoxycholic acid and Disease Models, Animal
| Article | Year |
|---|---|
Crosstalk network among multiple inflammatory mediators in liver fibrosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid | 2019 |
Cholemic nephropathy - Historical notes and novel perspectives.
Topics: Acute Kidney Injury; Animals; Bile Acids and Salts; Bile Ducts; Bilirubin; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Epithelial Cells; Hepatocytes; Humans; Jaundice, Obstructive; Kidney Tubules; Liver; Renal Elimination; Ursodeoxycholic Acid | 2018 |
9 other study(ies) available for 24-norursodeoxycholic acid and Disease Models, Animal
| Article | Year |
|---|---|
24-Norursodeoxycholic acid reshapes immunometabolism in CD8
Topics: Animals; CD8-Positive T-Lymphocytes; Disease Models, Animal; Inflammation; Liver; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid | 2021 |
NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
Topics: Adenylate Kinase; alpha 1-Antitrypsin; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Disease Models, Animal; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Diseases; Mice; Mutant Proteins; Proteolysis; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Ursodeoxycholic Acid | 2018 |
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
Topics: Animals; Cholagogues and Choleretics; Disease Models, Animal; Drug Monitoring; Granuloma; Immunohistochemistry; Inflammation; Liver Cirrhosis; Lymphocyte Activation; Mice; Schistosomiasis mansoni; T-Lymphocytes; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Biological Transport; CHO Cells; Cholestasis; Ciprofloxacin; Cricetulus; Disease Models, Animal; Female; Fluorine Radioisotopes; Liver; Mice, Knockout; Multidrug Resistance-Associated Proteins; Organ Specificity; Positron-Emission Tomography; Substrate Specificity; Tissue Distribution; Ursodeoxycholic Acid | 2016 |
Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Animals; Autophagy; Cells, Cultured; Deoxycholic Acid; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Liver; Liver Cirrhosis; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phenotype; Transfection; Ursodeoxycholic Acid | 2016 |
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
Topics: Animals; Bile Acids and Salts; Cholestasis; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Ligation; Lipocalin-2; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Ursodeoxycholic Acid | 2017 |
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
Topics: Animals; Anti-Bacterial Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; HEK293 Cells; Humans; Immunity, Innate; Inflammation Mediators; Keratin-19; Leukocyte Common Antigens; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Mice, Knockout; Neomycin; NF-kappa B; Phosphorylation; Polymyxin B; src-Family Kinases; Time Factors; Toll-Like Receptor 4; Transfection; Ursodeoxycholic Acid | 2011 |
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cell Proliferation; Cholestasis, Intrahepatic; Chronic Disease; Dietary Fats; Disease Models, Animal; Disease Progression; Fatty Acids; Female; Fenofibrate; Gene Expression Profiling; Gene Expression Regulation; Hepatitis; Hypolipidemic Agents; Lipid Metabolism; Liver; Liver Cirrhosis; Metabolomics; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Triglycerides; Ursodeoxycholic Acid | 2012 |
24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cholangitis, Sclerosing; Disease Models, Animal; Mice; Mice, Knockout; Ursodeoxycholic Acid | 2006 |